OpenAlex
PricingAboutJobs
Log inGet started
Author

F. Li

Institution: First Affiliated Hospital of Nanchang University
Observed institution: First Affiliated Hospital of Nanchang University
ORCID: 0000-0003-2492-9909
Observed ORCID: 0000-0003-2492-9909
OpenAlex ID: A5072545079
P1390: the Efficacy and Safety of Modified Melphalan and Busulfan-based Regimen for Allogeneic Transplantation in Refractory/relapsed Aml Patients
2022 · S. Chen, X. Zhang, et al. · HemaSphere · 2
MiR-137 contributes to drug susceptibility and chromosomal instability of multiple myeloma through targeting AURKA
2015 · Y. Qin, X. Qin, et al. · Clinical Lymphoma Myeloma & Leukemia · 2
A PHASE IB STUDY OF AN ORAL PI3Kδ INHIBITOR LINPERLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T CELL LYMPHOMA
2021 · L. Qiu, J. Jin, et al. · Hematological Oncology · 1
PDF
Pb1999: Atg-010 Plus Low-dose Dexamethasone (sd) in Chinese Relapsed/refractory Multiple Myeloma (rrmm) Patients Previously Received Chimeric Antigen Receptor T-cell (car-t)
2022 · W. Fu, Z. Xia, et al. · HemaSphere
Pb1949: Eltrombopag in Chinese Patients With Refractory or Relapsed Severe Aplastic Anemia: a Non-randomized, Open-label, Multicenter, Phase Ii Study Assessing the Safety and Efficacy of Eltrombopag
2022 · H. Chang, G. He, et al. · HemaSphere
Works count: 5
Citation count: 5
H-index: 2
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms